A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin’s disease
- 1 December 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (13) , 2058-2063
- https://doi.org/10.1016/s0959-8049(98)00314-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.Journal of Clinical Oncology, 1997
- Gonadal function following chemotherapy for childhood Hodgkin's diseaseMedical and Pediatric Oncology, 1996
- ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.Journal of Clinical Oncology, 1994
- Second cancer risk following Hodgkin's disease: a 20-year follow-up study.Journal of Clinical Oncology, 1994
- Drugs ten years later: EpirubicinAnnals of Oncology, 1993
- Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease.Journal of Clinical Oncology, 1993
- Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.Journal of Clinical Oncology, 1992
- Early menopause in long-term survivors of cancer during adolescenceAmerican Journal of Obstetrics and Gynecology, 1992
- Treatment of clinical stage I Hodgkin's disease by local radiation therapy alone. A United Kingdom childrens cancer study group studyCancer, 1990
- The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult maleCancer, 1982